Concepedia

Ronald B. Moss

RB

Statistics

Publications

43

Citations

1.9K

H-Index

23

Active since

1989

Affiliations

Response Technologies (United States)(Current)

Response Biomedical (Canada)

Naval Medical Center San Diego

University of California San Diego

Adamis Pharmaceuticals (United States)

Ronald B. Moss is an author at Response Technologies (United States) specializing in infectious diseases, life sciences, and immunology.

ORCID

Publications per year

1989–2020

43

Publications

43

Higher doses of naloxone are needed in the synthetic opioid era

Ronald B. Moss, Dennis J. Carlo · Substance Abuse Treatment Prevention and Policy · 2019 · 154 citations · Full text

, , +17

Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin

Larry Smith, Mary K. Wloch, Ming Ye et al. · Vaccine · 2010 · 141 citations

, , +17

Spontaneous and antigen-induced production of HIV-inhibitory β-chemokines are associated with AIDS-free status

Alfredo Garzino‐Demo, Ronald B. Moss, Joseph B. Margolick et al. · Proceedings of the National Academy of Sciences · 1999 · 138 citations

, , +13

TNF-α and Chronic Fatigue Syndrome

Ronald B. Moss, Alexander Mercandetti, Aristo Vojdani · Journal of Clinical Immunology · 1999 · 138 citations

, , +4

CD4+CD8dim T lymphocytes exhibit enhanced cytokine expression, proliferation and cytotoxic activity in response to HCMV and HIV-1 antigens

Maria Suni, Smita Ghanekar, David W. Houck et al. · European Journal of Immunology · 2001 · 130 citations

, , +17

1–5 of 43